Associate Professor Daniele Pastori

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer.

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial fibrillation e-posters

Access

0

Prevalence of heart failure with preserved ejection fraction in antiphospholipid antibodies syndrome. The multicenter ATHERO-APS study.

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure e-posters

Access

0

Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study.

Event: EHRA 2021

Topic: Clinical

Session: Outcome of atrial fibrillation

Access

0

Comparison of bleeding risk scores in patients with atrial fibrillation and cancer.

Event: EHRA 2021

Topic: Clinical

Session: Outcome of atrial fibrillation

Access

0

Performance of the C2HEST score to predict sustained atrial high-rate episodes in patients implanted with cardiac implantable electronic device

Event: EHRA 2021

Topic: Clinical

Session: News about electrophysiology in general

Access

0

The Atrial fibrillation Better Care (ABC) pathway is associated to a lower incidence of cardiac complications in patients with atrial fibrillation: A report from the ATHERO-AF study

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Atrial Fibrillation from Care to Artificial Intelligence

Access

0

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Cardiovascular Risk Assessment

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes

Access

0

Risk of cardiovascular events in patients with atrial fibrillation and cancer. Data from the ATHERO-AF cohort.

Event: ESC CONGRESS 2020 - The Digital Experience

Topic: Clinical

Session: Arrhythmias, General ePosters

Access

0

PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation

Event: ESC CONGRESS 2019

Topic: Pathophysiology and Mechanisms

Session: Biomarkers in heart failure

Access

0

Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study.

Event: ESC CONGRESS 2019

Topic: Anticoagulants

Session: Anticoagulant therapy

Access

0

Associate Professor Daniele Pastori

Contributor content

Comparison of the HAS-BLED, ORBIT and ATRIA bleeding risk scores in 399,344 patients with atrial fibrillation and cancer.

Prevalence of heart failure with preserved ejection fraction in antiphospholipid antibodies syndrome. The multicenter ATHERO-APS study.

Risks of thromboembolism, mortality and bleeding in 2,435,541 atrial fibrillation patients with and without cancer: a nationwide cohort study.

Comparison of bleeding risk scores in patients with atrial fibrillation and cancer.

Performance of the C2HEST score to predict sustained atrial high-rate episodes in patients implanted with cardiac implantable electronic device

The Atrial fibrillation Better Care (ABC) pathway is associated to a lower incidence of cardiac complications in patients with atrial fibrillation: A report from the ATHERO-AF study

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis.

Risk of cardiovascular events in patients with atrial fibrillation and cancer. Data from the ATHERO-AF cohort.

PCSK9 as a predictor of cardiovascular events in atrial fibrillation: role of platelet activation

Modifications of renal function in atrial fibrillation patients treated with different oral anticoagulants: a multicentre cohort study.

This platform is supported by